Get the Stockscreener App
11.64
0.09%
0.010
Retension Pharmaceuticals, Inc. Common Stock stock is traded at $11.64, with a volume of 77,190.
It is up +0.09% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$11.63
Open:
$11.63
24h Volume:
77,190
Relative Volume:
0.59
Market Cap:
$96.98M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$10.16
$12.50
52-Week Range:
$10.16
$12.50
Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Company Profile
Name
Retension Pharmaceuticals, Inc. Common Stock
Sector
Industry
Phone
-
Address
-
Compare RTSN vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RTSN
Retension Pharmaceuticals, Inc. Common Stock
|
11.64 | 96.98M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Latest News
With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. - Stock Titan
CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan
A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). - Stock Titan
Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan
Total common shares outstanding of RETENSION PHARMACEUTICALS INC – NASDAQ:RTSN - TradingView
Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest press releases and corporate news - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) analyst ratings, estimates and forecasts - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) cash flow - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock historical prices and data - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) company profile and facts - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) options chain - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
RTSN Interactive Stock Chart | Retension Pharmaceuticals, Inc. Common Stock Stock - Yahoo Finance
Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Ratings, Estimates & ForecastsYahoo Finance - Yahoo! Finance Canada
Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest stock news and headlines - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) interactive stock chart - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock major holders - Yahoo Finance UK
Retension Pharmaceuticals Announces Pricing of Initial Public Offering - Yahoo! Finance Canada
Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock price, news, quote and history - Yahoo Finance UK
Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Financials Data
There is no financial data for Retension Pharmaceuticals, Inc. Common Stock (RTSN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Oct 13 '26 |
Buy |
12.00 |
10,000 |
120,000 |
10,000 |
6.10%
5.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):